Skip to main content

and
  1. No Access

    Article

    Long-term survival after systemic chemotherapy, chemoradiotherapy, and maintenance therapy for an older adult patient with recurrent pancreatic acinar cell carcinoma

    Pancreatic acinar cell carcinoma (PACC) is a rare cancer with no specific treatment. The treatment and chemotherapy for PACC are selected according to pancreatic ductal adenocarcinoma (PDAC). Herein, we descri...

    Makiko Urabe, Kenji Ikezawa, Kazuhiro Kozumi in Clinical Journal of Gastroenterology (2024)

  2. No Access

    Article

    Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer

    Although patients with advanced pancreatic cancer (PC) often experience dysgeusia with zinc deficiency during chemotherapy, data on zinc supplementation for dysgeusia and its effects on nutritional status are ...

    Yusuke Seiki, Kenji Ikezawa, Ko Watsuji in International Journal of Clinical Oncology (2024)

  3. Article

    Open Access

    Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer

    Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU)/levo-leucovorin (Levo-LV) was approved for unresectable pancreatic cancer (UR-PC) in March 2020 in Japan. Levo-LV is administered by intravenous infus...

    Ryoji Takada, Kenji Ikezawa, Takuo Yamai, Ko Watsuji, Yusuke Seiki in BMC Cancer (2023)